Tachykinin receptor antagonists in clinical trials

Expert Opinion on Investigational Drugs
Laura QuartaraC A Maggi

Abstract

Tachykinins (TKs) are small peptides widely distributed in the central and peripheral nervous systems where they act as neurotransmitters. Potent and selective TKs antagonists have been developed in the last 20 years and many efforts have been made to prove their efficacy in the treatment of various diseases. Herein the most prominent results in the clinical development are reported and discussed. For aprepitant, the only compound of this class to have been launched to date, results of clinical studies and postmarketing cost-effectiveness data for the treatment of chemotherapy-induced emesis are discussed. The field is still well active, as currently proof-of-concept studies for indications initially missed (i.e., depression) are ongoing and new targets are under investigation.

References

Feb 1, 1993·Journal of Autonomic Pharmacology·C A MaggiA Giachetti
Jan 1, 1997·British Journal of Pharmacology·J B LucotJ W Watson
Mar 4, 1998·British Journal of Pharmacology·R M CataliotoC A Maggi
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R J GrallaD G Pfister
Feb 29, 2000·British Journal of Pharmacology·M ToulouseL Buéno
Jun 29, 2000·Trends in Pharmacological Sciences·R Hill
Feb 13, 2001·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·M ToulouseL Buéno
Mar 7, 2001·Trends in Pharmacological Sciences·L A Urban, A J Fox
Mar 17, 2001·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·J KraanD S Postma
Apr 12, 2001·Neuroscience Letters·M BensaidF Oury-Donat
Nov 8, 2001·European Journal of Pharmacology·R Patacchini, C A Maggi
Jun 12, 2002·Canadian Journal of Physiology and Pharmacology·Xavier Emonds-AltMarc Pascal
May 9, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P J HeskethK J Horgan
Jul 5, 2003·Clinical Pharmacology and Therapeutics·Jacqueline B McCreaRobert A Blum
Jul 18, 2003·Clinical Therapeutics·Robert A BlumHoward E Greenberg
Oct 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R de WitK J Horgan
Nov 11, 2003·Trends in Pharmacological Sciences·Andrew HolmesGuy Griebel
Dec 11, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Mark S KramerYih Lee
Jun 1, 2004·The American Journal of Psychiatry·Herbert Y MeltzerUNKNOWN Meta-Trial Study Group
Jul 29, 2004·Current Medicinal Chemistry·T A AlmeidaM L Candenas
Feb 3, 2005·Nature Reviews. Drug Discovery·Curtis T KeithBrent R Stockwell
Jun 29, 2005·European Journal of Clinical Pharmacology·M DepréJ N de Hoon
Nov 25, 2005·Autonomic Neuroscience : Basic & Clinical·Hikma Boutaghou-CheridMarie-Odile Christen
Apr 18, 2006·Autonomic Neuroscience : Basic & Clinical·Alessandro LecciCarlo Alberto Maggi
Aug 12, 2006·Vascular Pharmacology·Gareth J SangerJohn B Furness
Sep 19, 2006·European Journal of Pharmacology·Cecilia CialdaiCarlo Alberto Maggi
Dec 1, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Florian LordickRobert Deuson

❮ Previous
Next ❯

Citations

May 1, 2012·TheScientificWorldJournal·Marisa RossoMichael Berger
Oct 14, 2010·Journal of Leukocyte Biology·Linda Monaco-ShawverJordan S Orange
Dec 14, 2011·Expert Opinion on Therapeutic Patents·Maria Altamura
Jan 15, 2014·Expert Review of Gastroenterology & Hepatology·Guy BoeckxstaensJan Tack
Jan 19, 2011·Expert Opinion on Drug Metabolism & Toxicology·Mario Pellegatti, Sabrina Pagliarusco
Sep 28, 2010·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Luca FerrariMarco Michi
May 21, 2010·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Mark J MillanGuillaume de Nanteuil
Oct 1, 2010·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·G CiprianiM G Vannucchi
Jun 10, 2011·British Journal of Clinical Pharmacology·Joop van Gerven, Adam Cohen
Feb 20, 2014·Medicinal Research Reviews·Dong GuoLaura H Heitman
Sep 3, 2013·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·D AngJ Tack
Jun 20, 2015·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·M CorsettiJ Tack
Jan 1, 2014·Bioorganic & Medicinal Chemistry Letters·Stephen HanessianGuillaume De Nanteuil
Feb 5, 2013·European Journal of Pharmacology·Paolo SanticioliCarlo Alberto Maggi
Jan 8, 2016·Experimental Dermatology·Sattar OstadhadiAhmad-Reza Dehpour
Oct 14, 2016·JCI Insight·Ehsan AzimiEthan A Lerner
Jan 19, 2018·Journal of Leukocyte Biology·Sergei SpitsinSteven D Douglas
Nov 6, 2013·International Journal of Oncology·Miguel MuñozRafael Coveñas
Oct 28, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Sabrina PagliaruscoMario Pellegatti
Jul 20, 2014·The Journal of Pharmacology and Experimental Therapeutics·Jesse R Schank
Sep 5, 2019·Pharmaceutics·Agnieszka Majkowska-PilipEwa Gniazdowska
Sep 7, 2019·Proceedings of the National Academy of Sciences of the United States of America·Chentao GeCaiyun Fu
Apr 5, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hidemitsu KitamuraTakashi Nishimura
Jun 1, 2013·Biomolecular Concepts·Maria Giuliana Vannucchi, Stefano Evangelista
Feb 13, 2015·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Li LiJun-Qiang Si
Dec 13, 2018·Proceedings of the National Academy of Sciences of the United States of America·Jie YinDaniel M Rosenbaum
Jan 20, 2017·Frontiers in Cellular Neuroscience·M Brittany JohnsonIan Marriott
Nov 7, 2019·Nature Nanotechnology·Paulina D Ramírez-GarcíaNigel W Bunnett
Aug 23, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Paweł K HalikEwa Gniazdowska
May 18, 2021·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Nan WangLangchong He
Sep 18, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Esra Nizam, Nuray Erin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.